Behavioral Phenotyping Assays for Genetic Mouse Models of Neurodevelopmental, Neurodegenerative, and Psychiatric Disorders
- PMID: 28199172
- DOI: 10.1146/annurev-animal-022516-022754
Behavioral Phenotyping Assays for Genetic Mouse Models of Neurodevelopmental, Neurodegenerative, and Psychiatric Disorders
Abstract
Animal models offer heuristic research tools to understand the causes of human diseases and to identify potential treatments. With rapidly evolving genetic engineering technologies, mutations identified in a human disorder can be generated in the mouse genome. Phenotypic outcomes of the mutation are then explicated to confirm hypotheses about causes and to discover effective therapeutics. Most neurodevelopmental, neurodegenerative, and psychiatric disorders are diagnosed primarily by their prominent behavioral symptoms. Mouse behavioral assays analogous to the human symptoms have been developed to analyze the consequences of mutations and to evaluate proposed therapeutics preclinically. Here we describe the range of mouse behavioral tests available in the established behavioral neuroscience literature, along with examples of their translational applications. Concepts presented have been successfully used in other species, including flies, worms, fish, rats, pigs, and nonhuman primates. Identical strategies can be employed to test hypotheses about environmental causes and gene × environment interactions.
Keywords: behavior; genetics; knockout; mouse; neurodegenerative; neurodevelopmental; phenotype; psychiatric; transgenic.
Similar articles
-
In tribute to Bob Blanchard: Divergent behavioral phenotypes of 16p11.2 deletion mice reared in same-genotype versus mixed-genotype cages.Physiol Behav. 2015 Jul 1;146:16-27. doi: 10.1016/j.physbeh.2015.04.023. Physiol Behav. 2015. PMID: 26066718
-
Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls.ILAR J. 2006;47(2):124-31. doi: 10.1093/ilar.47.2.124. ILAR J. 2006. PMID: 16547369 Review.
-
The genes and brains of mice and men.Am J Psychiatry. 2003 Apr;160(4):646-56. doi: 10.1176/appi.ajp.160.4.646. Am J Psychiatry. 2003. PMID: 12668350 Review.
-
Behavioral phenotyping strategies for mutant mice.Neuron. 2008 Mar 27;57(6):809-18. doi: 10.1016/j.neuron.2008.03.001. Neuron. 2008. PMID: 18367082 Review.
-
Intrauterine environment-genome interaction and children's development (4): Brain-behavior phenotypying of genetically-engineered mice using a comprehensive behavioral test battery on research of neuropsychiatric disorders.J Toxicol Sci. 2009;34 Suppl 2:SP293-305. doi: 10.2131/jts.34.sp293. J Toxicol Sci. 2009. PMID: 19571483 Review.
Cited by
-
Phenotyping Young GluA1 Deficient Mice - A Behavioral Characterization in a Genetic Loss-of-Function Model.Front Behav Neurosci. 2022 Jun 2;16:877094. doi: 10.3389/fnbeh.2022.877094. eCollection 2022. Front Behav Neurosci. 2022. PMID: 35722188 Free PMC article.
-
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives.Vaccines (Basel). 2021 Nov 4;9(11):1278. doi: 10.3390/vaccines9111278. Vaccines (Basel). 2021. PMID: 34835209 Free PMC article. Review.
-
Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly/autism phenotypes.Genes Dev. 2020 Apr 1;34(7-8):580-597. doi: 10.1101/gad.332494.119. Epub 2020 Feb 27. Genes Dev. 2020. PMID: 32115408 Free PMC article.
-
Calcium Imaging in Drug Discovery for Psychiatric Disorders.Front Psychiatry. 2020 Jul 23;11:713. doi: 10.3389/fpsyt.2020.00713. eCollection 2020. Front Psychiatry. 2020. PMID: 32793004 Free PMC article. Review.
-
Microbial glutamate metabolism predicts intravenous cocaine self-administration in diversity outbred mice.Neuropharmacology. 2023 Mar 15;226:109409. doi: 10.1016/j.neuropharm.2022.109409. Epub 2022 Dec 30. Neuropharmacology. 2023. PMID: 36592885 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources